BSCL2 anticorps (C-Term)
Aperçu rapide pour BSCL2 anticorps (C-Term) (ABIN928313)
Antigène
Voir toutes BSCL2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Purified
-
Immunogène
- BSCL2 antibody was raised in rabbit using the C terminal of BSCL2 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
BSCL2 Blocking Peptide, (ABIN5612369), is also available for use as a blocking control in assays to test for specificity of this BSCL2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- BSCL2 (Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2))
-
Autre désignation
- BSCL2
-
Sujet
- This gene encodes protein seipin, which is located in the endoplasmic reticulum and may be important for lipid droplet morphology. Mutations in this gene have been associated with congenital generalized lipodystrophy type 2 or Berardinelli-Seip syndrome, a rare autosomal recessive disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Synonyms: Polyclonal BSCL2 antibody, Anti-BSCL2 antibody, Berardinelli-Seip congenital lipodystrophy 2, seipin antibody, GNG3LG antibody, HMN5 antibody, MGC4694 antibody, SPG17 antibody.
Antigène
-